“No Time to Stop the Momentum”

Former Vice President Joe Biden returned to the stage at the American Association for Cancer Research (AACR) Annual Meeting on Monday, sounding a battle cry to continue the momentum for cancer research that began when he launched the National Cancer Moonshot Initiative in 2016.

Read More

AACR Annual Meeting 2017: Immunotherapy Provides Long-lasting Responses to Certain Cancer Types

Now that a plethora of clinical trials have established positive responses from immunotherapies—immune checkpoint inhibitors, in particular—in patients with a variety of cancer types, one of the logical next questions is, are the responses durable?

Read More

FDA Approves New PARP Inhibitor for Ovarian Cancer

Earlier this week, the U.S. Food and Drug Administration (FDA) approved the molecularly targeted therapeutic niraparib (Zejula) for the maintenance treatment of adult patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancers that are responding to platinum-based chemotherapy.

Read More

AACR Speaks Out on Proposed Cuts to Medical Research Funding

The American Association for Cancer Research was shocked last week to learn that the Trump administration has proposed to cut $5.8 billion from the National Institutes of Health (NIH) budget in fiscal year 2018. We are working very hard to ensure that these proposed cuts to the NIH never happen.

Read More

New Therapeutic Approved by FDA to Treat Breast Cancer

Earlier this week, the U.S. Food and Drug Administration approved the molecularly targeted therapeutic ribociclib (Kisqali) for use in combination with any aromatase inhibitor for initial treatment of postmenopausal women with a hormone receptor (HR)–positive, HER2-negative, advanced breast cancer.

Read More

Why Shouldn’t I Tan Indoors?

Before you try to banish the winter blues by adding some color to your skin with a trip to the tanning salon, remember that exposure to ultraviolet (UV) light from indoor tanning beds, sunlamps, and tanning booths increases your risk of developing skin cancer.

Read More